Effect of treatment on cognitive and attention problems in children with narcolepsy type 1.

cognition inattention narcolepsy with cataplexy perception vigilance

Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
14 12 2020
Historique:
received: 04 02 2020
revised: 30 04 2020
pubmed: 7 6 2020
medline: 15 4 2021
entrez: 7 6 2020
Statut: ppublish

Résumé

To ascertain the presence of cognitive and attention problems in treatment naïve children with narcolepsy type 1 (NT1) and to explore whether children recently diagnosed with NT1 improve with respect to cognition and attention problems 1 year after regular treatment for NT1. A total of 15 treatment naïve children (7-15 years) with recently diagnosed NT1 were recruited from three sleep medicine centers in the Netherlands. The control group consisted of 15 healthy children, being frequency matched on age and gender. Both groups were investigated at baseline to examine intelligence profile (Wechsler Intelligence Scale for Children [WISC] III), attention problems, and processing speed (Bourdon Vos and sustained attention to respond task [SART]). These tests were repeated in children with NT1 1 year after regular (behavioral and medication) treatment for NT1. Children with NT1 scored significantly lower on the verbal scale and processing speed subscale of the WISC III, showed more fluctuations in reaction time of the Bourdon Vos and made more mistakes during the SART than the healthy control group at baseline. Children with NT1 significantly improved on total IQ score, and on the WISC indices processing speed, and perceptual organization 1 year after treatment. At follow-up, test scores of treated children were largely comparable to those of the control group at baseline. Children with NT1 show improvement in several cognitive domains 1 year after start of treatment. Our findings stress the need for early detection and treatment of narcolepsy in childhood.

Identifiants

pubmed: 32505131
pii: 5854315
doi: 10.1093/sleep/zsaa114
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Auteurs

Karin A M Janssens (KAM)

Sleep-Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Zwolle/Heemstede, The Netherlands.

Laury Quaedackers (L)

Center for Sleep Medicine, Kempenhaeghe, Heeze, The Netherlands.
Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands.

Gert Jan Lammers (GJ)

Sleep-Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Zwolle/Heemstede, The Netherlands.

Pauline Amesz (P)

Sleep-Wake Centre, Stichting Epilepsie Instellingen Nederland (SEIN), Zwolle/Heemstede, The Netherlands.

Petra van Mierlo (P)

Center for Sleep Medicine, Kempenhaeghe, Heeze, The Netherlands.

Lisanne Aarts (L)

Center for Sleep Medicine, Kempenhaeghe, Heeze, The Netherlands.

Els Peeters (E)

Department of Child Neurology, Juliana Children's Hospital-Haga Teaching Hospital, The Hague, The Netherlands.
Sleeping Center, Medical Centre Haaglanden, The Hague, The Netherlands.

Danielle Hendriks (D)

Sleeping Center, Medical Centre Haaglanden, The Hague, The Netherlands.

Nele Vandenbussche (N)

Center for Sleep Medicine, Kempenhaeghe, Heeze, The Netherlands.

Sebastiaan Overeem (S)

Center for Sleep Medicine, Kempenhaeghe, Heeze, The Netherlands.
Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands.

Sigrid Pillen (S)

Center for Sleep Medicine, Kempenhaeghe, Heeze, The Netherlands.
Department of Industrial Design, Eindhoven University of Technology, Eindhoven, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH